What’s the biggest regulatory worry you have about your direct-to-consumer advertising campaign?

Is it getting an FDA warning letter?

Having Congress ban the ads entirely?

Or maybe a state investigation?

Whatever is rattling your nerves, this audioconference from FDC-Windhover will give you the information you need to navigate this shifting terrain. FDA and the states have increased their enforcement recently, and here’s your chance to learn about the changing data and behavior requirements.

Topics to be addressed include ...

• The rise of states as advertising enforcers
• FDA’s latest concerns about the claims and images in DTC ads
• The political trends that could change oversight patterns
• How drug safety concerns are affecting promotions
• What changes may be in the works for DTC print coupons

... and much more!

With marketing budgets continuing to be pulled tight, this audioconference can help you avoid costly corrective campaigns and enforcement fines. Sign up now for this valuable insight! For one low price (just $299 through May 13; $399 after), you and your entire team from one location can take part in this fast-paced, insightful web conference from FDC-Windhover. Best of all, you’ll be able to connect personally with our expert panelists by typing your questions into the website during the event, and when we open up the phone lines for live Q&A.

	DAVID HART joined the Financial Fraud/Consumer Protection Section of the Oregon Department of Justice in 2000 after a 15-year career practicing as a Physical Therapist in hospitals, nursing homes and home health agencies in New York City and Portland, Oregon. He has organized and led numerous multistate investigations by state Attorneys General relating to the marketing of pharmaceuticals and medical devices. Most recently, David led state consumer protection actions relating to Vioxx, Zyprexa, and Bextra that resulted in significant multistate settlements. Mr. Hart has a B.A. degree in Government from Oberlin College, a B.S. in Pathokinesiology from New York University, and a J.D. from the Northwest School of Law at Lewis and Clark College.
	ARNOLD FRIEDE is counsel to the law firm of McDermott, Will & Emery LLP, based in its Washington, DC office. Mr. Friede is a widely respected food and drug law counselor and advocate with significant advertising law, health care law, First Amendment, environmental, and commercial and transactional experience. He served in government as a law clerk in Federal District Court in Los Angeles, and then with the Federal Judicial Panel on Multidistrict Litigation in Washington, DC, and as an Associate Chief Counsel in the FDA Chief Counsel's Office in Rockville, Maryland. He has also served with Richardson-Vicks in Wilton, CT and then with several divisions of Unilever United States, including as General Counsel of Unilever’s U .S. food business in New Jersey, and then as senior corporate counsel with Pfizer in New York. Mr. Friede received his B.S. degree in Mathematics from the University of Pittsburgh and his J.D. from the George Washington University School of Law.

Webinar presented by

FDC-Windhover Webinars
Elsevier Business Intelligence
P.O. Box 7247
Philadelphia, PA 19101-9257
* Tel: +1 (800) 332-2181 (U.S.)
or +1 (908) 547-2159 (non-U.S.)
* Fax: +1 (908) 547-2165